[Skip to Content]
[Skip to Content Landing]

November 2019 - July 1883

Decade

Year

Issue

September 24, 2019, Vol 322, No. 12, Pages 1121-1222

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2019;322(12):1121-1123. doi:10.1001/jama.2018.15520
Original Investigation

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial

Abstract Full Text
JAMA. 2019;322(12):1155-1166. doi:10.1001/jama.2019.13772

This randomized noninferiority clinical trial examines the effect of treatment with the dipeptidyl peptidase-4 inhibitor linagliptin vs the commonly used sulfonylurea glimepiride on cardiovascular safety in patients with type 2 diabetes and cardiovascular risk factors or established atherosclerotic cardiovascular disease.

Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function

Abstract Full Text
JAMA. 2019;322(12):1167-1177. doi:10.1001/jama.2019.13206

This cohort study uses data from the National Veterans Health Administration, Medicare, Medicaid, and National Death Index to compare major adverse cardiovascular events among patients with diabetes and reduced kidney function who continued treatment with metformin or sulfonylurea.

Trends in Dietary Carbohydrate, Protein, and Fat Intake and Diet Quality Among US Adults, 1999-2016

Abstract Full Text
has active quiz
JAMA. 2019;322(12):1178-1187. doi:10.1001/jama.2019.13771

This national survey study uses NHANES data to characterize trends in dietary macronutrient intake, food sources, and diet quality among US adults from 1999 to 2016.

Research Letter

Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer

Abstract Full Text
JAMA. 2019;322(12):1209-1211. doi:10.1001/jama.2019.10650

This research letter discusses the association between label restrictions by the US Food and Drug Administration on first-line immunotherapy for advanced bladder cancer and subsequent changes in practice.

US Preventive Services Task Force

Recommendation Statement

Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement

Abstract Full Text
free access has active quiz has audio
JAMA. 2019;322(12):1188-1194. doi:10.1001/jama.2019.13069

This 2019 Recommendation Statement from the US Preventive Services Task Force recommends screening pregnant persons for asymptomatic bacteriuria using urine culture (B recommendation) and recommends against screening for asymptomatic bacteriuria in nonpregnant adults (D recommendation).

Evidence Report

Screening for Asymptomatic Bacteriuria in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Abstract Full Text
free access has audio
JAMA. 2019;322(12):1195-1205. doi:10.1001/jama.2019.10060

This systematic review to support the 2019 US Preventive Services Task Force Recommendation Statement on screening for asymptomatic bacteriuria in adults summarizes published evidence on the benefits and harms of asymptomatic bacteriuria screening and treatment in adults, including during pregnancy.

Viewpoint

The Relative Value Scale Update Committee: Time for an Update

Abstract Full Text
JAMA. 2019;322(12):1137-1138. doi:10.1001/jama.2019.14591

This Viewpoint discusses how problems with the methodology, structure, and recommendations of the Relative Value Scale Update Committee can lead to outdated or inaccurate physician payment data and lower quality of care, and calls for the use of empirical data and patient-specific outcomes to inform physician reimbursement.

Relative Value Units and the Measurement of Physician Performance

Abstract Full Text
has audio
JAMA. 2019;322(12):1139-1140. doi:10.1001/jama.2019.11163

This Viewpoint argues for separation of physician performance measurement from RVU production as a means to refocus physicians away from billing toward patient-centered values that could improve patients’ experience, reduce potential harms from the overtreatment that RVUs incentivize, and improve physicians’ work life and satisfaction.

Big Data, Big Tech, and Protecting Patient Privacy

Abstract Full Text
JAMA. 2019;322(12):1141-1142. doi:10.1001/jama.2019.11365

This Viewpoint uses Dinerstein v Google, a class action complaint in Illinois alleging that an academic medical center violated patient privacy by giving timestamped electronic health record (EHR) data to Google for development of their novel EHR system, to review the ways privacy laws like HIPAA are based on outdated technologies and data transfer standards and to call for a rethinking of data sharing governance appropriate to contemporary infrastructure and expectations of interoperability.

Improvements to the US Preventive Services Task Force Recommendation Statement

Abstract Full Text
JAMA. 2019;322(12):1143-1144. doi:10.1001/jama.2019.11311

This Viewpoint summarizes results of dissemination and implementation research conducted by the US Preventive Services Task Force (USPSTF) to reevaluate the presentation of USPSTF Recommendation Statements and explains changes made to the statements and accompanying materials to increase clarity and enhance implementation of recommendations.

A Piece of My Mind

A Teacher for All Seasons

Abstract Full Text
JAMA. 2019;322(12):1145-1146. doi:10.1001/jama.2019.14741

In this narrative medicine essay, a gastroenterologist describes the challenge of diagnosing a partner in his clinic with pancreatic cancer, which came a day short of the median time patients present and are diagnosed with the disease, and reflects on the positive example his colleague had on him, his career, and on the other physicians working at the clinic.

Editorial

Sulfonylureas and Cardiovascular Safety: The Final Verdict?

Abstract Full Text
JAMA. 2019;322(12):1147-1149. doi:10.1001/jama.2019.14533

US Dietary Guidance—Is It Working?

Abstract Full Text
JAMA. 2019;322(12):1150-1151. doi:10.1001/jama.2019.13976

Updated Guidelines for Screening for Asymptomatic Bacteriuria

Abstract Full Text
has audio
JAMA. 2019;322(12):1152-1154. doi:10.1001/jama.2019.11640
From The Medical Letter on Drugs and Therapeutics

Estradiol/Progesterone (Bijuva) for Menopausal Vasomotor Symptoms

Abstract Full Text
JAMA. 2019;322(12):1206-1207. doi:10.1001/jama.2019.10692

This Medical Letter review summarizes prescribing information for Bijuva, a fixed-dose combination of “bioidentical” estradiol and progesterone, for oral treatment of moderate to severe vasomotor symptoms due to menopause in women with an intact uterus.

Medical News & Perspectives

Green Vegetables, Herbs, and Oils May Help Stabilize Patients Taking Warfarin

Abstract Full Text
has audio
JAMA. 2019;322(12):1128-1129. doi:10.1001/jama.2019.13060

This Medical News article discusses recent research that shows increasing their vitamin K intake could help patients who take warfarin to maintain stable anticoagulation.

Wild Health

Pigs Model Human Brains, Snake Fangs Inspire Microneedles, and Canines Advance Cardiac Imaging

Abstract Full Text
JAMA. 2019;322(12):1130-1131. doi:10.1001/jama.2019.12580

This Medical News article discusses how pigs, rear-fanged snakes, and dogs may help improve our understanding of brain connectivity, vaccine delivery, and myocardial oxygenation.

The JAMA Forum

Federalism as an Antidote to Polarization Over Health Care Policy

Abstract Full Text
free access
JAMA. 2019;322(12):1131-1132. doi:10.1001/jama.2019.14114
News From the Centers for Disease Control and Prevention

Uptick in Neuroinvasive West Nile

Abstract Full Text
JAMA. 2019;322(12):1135. doi:10.1001/jama.2019.14682

Boosting Naloxone Prescribing

Abstract Full Text
JAMA. 2019;322(12):1135. doi:10.1001/jama.2019.13931
Clinical Trials Update

Mediterranean Diet During Pregnancy

Abstract Full Text
JAMA. 2019;322(12):1134. doi:10.1001/jama.2019.13918

CBT Curbs Internet and Gaming Addiction

Abstract Full Text
JAMA. 2019;322(12):1134. doi:10.1001/jama.2019.14754

Cannabinoid Agonist Reduces Cannabis Use

Abstract Full Text
JAMA. 2019;322(12):1134. doi:10.1001/jama.2019.14755

Fecal Transplant Doesn’t Improve Symptoms of IBS

Abstract Full Text
JAMA. 2019;322(12):1134. doi:10.1001/jama.2019.14756

Adjuvant Therapy for HER2-Positive Breast Cancer

Abstract Full Text
JAMA. 2019;322(12):1134. doi:10.1001/jama.2019.14757
Health Agencies Update

“Smoldering” Brain Lesions Might Signal Severe Multiple Sclerosis

Abstract Full Text
JAMA. 2019;322(12):1133. doi:10.1001/jama.2019.14344

Medicare to Cover CAR T-Cell Therapies

Abstract Full Text
JAMA. 2019;322(12):1133. doi:10.1001/jama.2019.14752

US Share of Funding Toward Global Tobacco Control

Abstract Full Text
JAMA. 2019;322(12):1133. doi:10.1001/jama.2019.14753
Poetry and Medicine

Chairside Fantasy

Abstract Full Text
JAMA. 2019;322(12):1216. doi:10.1001/jama.2019.7442
JAMA Revisited

Miscellany

Abstract Full Text
JAMA. 2019;322(12):1217. doi:10.1001/jama.2018.15528
JAMA Patient Page

Screening for Asymptomatic Bacteriuria

Abstract Full Text
free access has audio
JAMA. 2019;322(12):1222. doi:10.1001/jama.2019.14876

This JAMA Patient Page describes the US Preventive Services Task Force’s recent recommendations on screening for asymptomatic bacteriuria in adults.

Comment & Response

Unrecognized Obstructive Sleep Apnea in Patients Undergoing Surgery

Abstract Full Text
JAMA. 2019;322(12):1211. doi:10.1001/jama.2019.10990

Unrecognized Obstructive Sleep Apnea in Patients Undergoing Surgery—Reply

Abstract Full Text
JAMA. 2019;322(12):1211-1212. doi:10.1001/jama.2019.10994

Measuring the Quality of Diabetes Care

Abstract Full Text
JAMA. 2019;322(12):1212. doi:10.1001/jama.2019.11136

Measuring the Quality of Diabetes Care—Reply

Abstract Full Text
JAMA. 2019;322(12):1212-1213. doi:10.1001/jama.2019.11148

Publication Bias in Trials With and Without Null Findings

Abstract Full Text
JAMA. 2019;322(12):1213-1214. doi:10.1001/jama.2019.11140

Publication Bias in Trials With and Without Null Findings—Reply

Abstract Full Text
JAMA. 2019;322(12):1214. doi:10.1001/jama.2019.11144

Clarification of Reporting of Potential Conflicts of Interest in JAMA Articles

Abstract Full Text
JAMA. 2019;322(12):1214-1215. doi:10.1001/jama.2019.12743
Correction

Clarification of Reporting of Potential Conflicts of Interest in 2 Articles

Abstract Full Text
free access
JAMA. 2019;322(12):1215. doi:10.1001/jama.2019.14523

Error in Text

Abstract Full Text
free access
JAMA. 2019;322(12):1215. doi:10.1001/jama.2019.12944

Misspelling in Author Surname

Abstract Full Text
free access
JAMA. 2019;322(12):1215. doi:10.1001/jama.2019.14138
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2019;322(12):1125-1126. doi:10.1001/jama.2018.15521
×